Proton Pump Inhibitors, Dual Antiplatelet Therapy, and the Risk of Gastrointestinal Bleeding

被引:3
|
作者
Marlicz, Wojciech [1 ]
Loniewski, Igor [2 ]
Koulaouzidis, George [2 ]
机构
[1] Pomeranian Med Univ, Dept Gastroenterol, Unii Lubelskiej 1, PL-71252 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Biochem Sci, Szczecin, Poland
关键词
MYOCARDIAL-INFARCTION; ASSOCIATION; GUIDELINES; DISEASE;
D O I
10.1016/j.mayocp.2022.02.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:648 / 651
页数:4
相关论文
共 50 条
  • [31] Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy
    Huang, Jiaming
    Liao, Foqiang
    Tang, Jianhua
    Shu, Xu
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 231
  • [32] Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?
    Casado-Arroyo, Ruben
    Munoz-Villalenguas, Maria
    Lanas Arbeloa, Angel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (07): : 478 - 491
  • [33] The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Bleeding
    Leontiadis, Grigorios I.
    Howden, Colin W.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (02) : 199 - +
  • [34] Proton-pump inhibitors for upper-gastrointestinal bleeding
    Rivkin, K
    Lyakhovetskiy, A
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (03) : 216 - 217
  • [35] Intravenous administration of proton pump inhibitors in upper gastrointestinal bleeding
    Plevris, J. N.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2008, 38 (04): : 326 - 327
  • [36] PROTON-PUMP INHIBITORS REDUCE RISK OF GASTROINTESTINAL EVENTS REGARDLESS OF ASPIRIN DOSE IN PATIENTS REQUIRING DUAL ANTIPLATELET THERAPY: INSIGHTS FROM THE COGENT TRIAL
    Vaduganathan, Muthiah
    Bhatt, Deepak
    Cryer, Byron L.
    Liu, Yuyin
    Hsieh, Wen-Hua
    Doros, Gheorghe
    Cohen, Marc
    Lanas, Angel
    Schnitzer, Thomas J.
    Shook, Thomas
    Lapuerta, Pablo
    Goldsmith, Mark A.
    Laine, Loren
    Cannon, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2100 - 2100
  • [37] INDIVIDUAL PROTON PUMP INHIBITORS AND OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE ON DUAL ANTIPLATELET THERAPY
    Sherwood, Matthew W.
    Melloni, Chiara
    Jones, Schuyler
    Washam, Jeffrey
    Hasselblad, Victor
    Dolor, Rowena
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A203 - A203
  • [38] Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines
    Saven, Hannah
    Zhong, Lynna
    McFarlane, Isabel M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [39] The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study
    Ide, Yutaro
    Morikawa, Go
    Yoshida, Kyohei
    Takano, Yuki
    Kubota, Ken
    Okazawa, Katsuko
    Yasu, Takeo
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):
  • [40] Is proton pump inhibitors' prophylaxis indicated for patients on antiplatelet therapy?
    Porta, Lorenzo
    Baorda, Francesca
    Fusco, Alessandra
    INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (04) : 585 - 587